Abstract
Tominersen and Huntington’s Disease A trial of tominersen, designed to slow Huntington’s disease progression by lowering levels of huntingtin protein, was stopped prematurely, and an ad hoc analysi...
Cite
CITATION STYLE
APA
McColgan, P., Thobhani, A., Boak, L., Schobel, S. A., Nicotra, A., Palermo, G., … Doody, R. (2023). Tominersen in Adults with Manifest Huntington’s Disease. New England Journal of Medicine, 389(23), 2203–2205. https://doi.org/10.1056/nejmc2300400
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free